ArticleFrontiers in oncology2025

First-line therapy of osimertinib with chemotherapy in Chinese patients with EGFR mutation-positive non-small cell lung cancer: protocol for a multicenter, prospective, observational study.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.